Medical Journals Consider Requiring Registration for Clinical Trials

A group of medical journals is considering a proposal that would require drug makers to register clinical trials at their inception, as a condition for later publication of the results. The proposal comes in the wake of Eliot Spitzer's recent lawsuit charging the manufacturers of the drug Plaxil with touting one favorable clinical trial while playing down other, less successful ones. The New York Times has the details.